Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jialing Hao

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Biomedicines|August 28, 2025
Induced Pluripotent Stem Cell-Based Cancer Immunotherapy: Strategies and PerspectivesXiaodong Xun, Jialing Hao, Qian Cheng, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 5, 2023
UTMD inhibits pancreatic cancer growth and metastasis by inducing macrophage polarization and vessel normalizationLizhou Lin, Yichao Du, Jialing Hao, et al.
Journal of Oncology|September 8, 2022
A Genomic Instability-Related Long Noncoding RNA Signature for Predicting Hepatocellular Carcinoma PrognosisJing Lu, Wanyue Cao, Zeping He, et al.
Discover Oncology|July 6, 2026
Precision oncology in cholangiocarcinoma integrates molecular taxonomy testing strategies and treatment sequencingWenzai Shi, Ning Duan, Delin Ma, et al.
Carcinogenesis|November 1, 2022
TCL1A acts as a tumour suppressor by modulating gastric cancer autophagy via miR-181a-5p-TCL1A-Akt/mTOR-c-MYC loopJialing Hao, Haitao Mei, Qingshan Luo, et al.
Biomedicines|November 27, 2025
Molecular Mechanisms of the Ubiquitin-Specific Proteases (USPs) Family in Biliary Tract Cancer and Targeted Intervention StrategiesQian Cheng, Delin Ma, Shengmin Zheng, et al.
Cellular & Molecular Biology Letters|November 26, 2024
The miR-1269a/PCDHGA9/CXCR4/β-catenin pathway promotes colorectal cancer invasion and metastasisHaitao Mei, Qingshan Luo, Junyong Weng, et al.
Archives of Biochemistry and Biophysics|May 1, 2025
UGDH promotes 5-fluorouracil resistance in colorectal cancer via the ROS-activated PI3K/AKT-EEF1A2-PRDX1 pathwayJinfeng Cai, Runkai Zhou, Yingzi Ye, et al.
Cancer Medicine|February 4, 2022
Global burden of primary liver cancer by five etiologies and global prediction by 2035 based on global burden of disease study 2019Yuan Liu, Jinxin Zheng, Jialing Hao, et al.
Journal of Translational Medicine|November 16, 2024
Multi-omics-driven discovery of invasive patterns and treatment strategies in CA19-9 positive intrahepatic cholangiocarcinomaDelin Ma, Pengcheng Wei, Hengkang Liu, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Biomedicines|August 28, 2025
Induced Pluripotent Stem Cell-Based Cancer Immunotherapy: Strategies and PerspectivesXiaodong Xun, Jialing Hao, Qian Cheng, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 5, 2023
UTMD inhibits pancreatic cancer growth and metastasis by inducing macrophage polarization and vessel normalizationLizhou Lin, Yichao Du, Jialing Hao, et al.
Journal of Oncology|September 8, 2022
A Genomic Instability-Related Long Noncoding RNA Signature for Predicting Hepatocellular Carcinoma PrognosisJing Lu, Wanyue Cao, Zeping He, et al.
Discover Oncology|July 6, 2026
Precision oncology in cholangiocarcinoma integrates molecular taxonomy testing strategies and treatment sequencingWenzai Shi, Ning Duan, Delin Ma, et al.
Carcinogenesis|November 1, 2022
TCL1A acts as a tumour suppressor by modulating gastric cancer autophagy via miR-181a-5p-TCL1A-Akt/mTOR-c-MYC loopJialing Hao, Haitao Mei, Qingshan Luo, et al.
Biomedicines|November 27, 2025
Molecular Mechanisms of the Ubiquitin-Specific Proteases (USPs) Family in Biliary Tract Cancer and Targeted Intervention StrategiesQian Cheng, Delin Ma, Shengmin Zheng, et al.
Cellular & Molecular Biology Letters|November 26, 2024
The miR-1269a/PCDHGA9/CXCR4/β-catenin pathway promotes colorectal cancer invasion and metastasisHaitao Mei, Qingshan Luo, Junyong Weng, et al.
Archives of Biochemistry and Biophysics|May 1, 2025
UGDH promotes 5-fluorouracil resistance in colorectal cancer via the ROS-activated PI3K/AKT-EEF1A2-PRDX1 pathwayJinfeng Cai, Runkai Zhou, Yingzi Ye, et al.
Cancer Medicine|February 4, 2022
Global burden of primary liver cancer by five etiologies and global prediction by 2035 based on global burden of disease study 2019Yuan Liu, Jinxin Zheng, Jialing Hao, et al.
Journal of Translational Medicine|November 16, 2024
Multi-omics-driven discovery of invasive patterns and treatment strategies in CA19-9 positive intrahepatic cholangiocarcinomaDelin Ma, Pengcheng Wei, Hengkang Liu, et al.
Pageof 2